Several studies assessed CBD using contextual fear conditioning. Briefly, this paradigm involves pairing a neutral context, the conditioned stimulus (CS), with an aversive unconditioned stimulus (US), a mild foot shock. After repeated pairings, the subject learns that the CS predicts the US, and subsequent CS presentation elicits freezing and other physiological responses. Systemic administration of CBD prior to CS re-exposure reduced conditioned cardiovascular responses , an effect reproduced by microinjection of CBD into the BNST, and partially mediated by 5-HT1AR activation . Similarly, CBD in the prelimbic cortex reduced conditioned freezing , an effect prevented by 5-HT1AR blockade . By contrast, CBD microinjection in the infralimbic cortex enhanced conditioned freezing . Finally, El Batsh et al.  reported that repeated CBD doses over 21 days, that is chronic as opposed to acute treatment, facilitated conditioned freezing. In this study, CBD was administered prior to conditioning rather than prior to re-exposure as in acute studies, thus further directly comparable studies are required.
But, uh, what is it that CBD is supposed to do? I visited a cannabis dispensary in Boulder to find out what the hype was all about. After passing an ID check, I was introduced to a “budtender” who pointed me to an impressive array of CBD products — tinctures, skin patches, drink powders, candies, salves, massage oil, lotions, “sexy time personal intimacy oil” and even vaginal suppositories to treat menstrual cramps.
And of course, THC is what most recreational weed users are looking for, which is probably why botanists have figured out since the 1960’s how to increase the amount of THC from around 3% to 5% in the 1960s to as much as 28% in our current decade. So yes, it’s true that we’re not smoking the weed our parents smoked, and one draw on a typical joint these days would probably knock your mom on her ass.
58. Rock EM, Bolognini D, Limebeer CL, et al. Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol. 2012;165:2620–2634. doi: 10.1111/j.1476-5381.2011.01621.x. [PMC free article] [PubMed] [CrossRef]
The skin has the highest amount and concentration of CB2 receptors in the body. When applied topically as an infused lotion, serum, oil, or salve, the antioxidant (a more powerful antioxidant than vitamins E and C) in CBD oil has many benefits and can repair damage from free radicals like UV rays and environmental pollutants. Cannabinoid receptors can be found in the skin and seem to be connected to the regulation of oil production in the sebaceous glands. Cannabis-based topical products are being developed to treat related issues from acne to psoriasis and can promote faster healing of damaged skin. In fact, historical documents show that cannabis preparations have been used for wound healing in both animals and people in a range of cultures spanning the globe and going back thousands of years. The use of concentrated cannabis and CBD oils to benefit and treat skin cancer is gaining popularity with a number of well-documented cases of people curing both melanoma and carcinoma-type skin cancers with the topical application of CBD and THC products. Best known is the case of Rick Simpson, who cured his basal cell carcinoma with cannabis oil and now has a widely distributed line of products. Cannabis applied topically is not psychoactive.
There has been a fair amount of confusion surrounding the legality of CBD oil. But while the vast majority of cannabinoids are controlled substances under the Misuse of Drugs Act, rest assured that CBD oil is legal across the UK for medicinal purposes, provided it has been derived from an industrial hemp strain that is EU-approved. These strains contain very little to no THC (the psychoactive cannabinoid).
Several studies have found that the use of CBD oil is helpful in reducing anxiety, meaning it could be a beneficial natural remedy for sufferers. Back in 2011, a study published in the journal Neuropsychopharmacology found that when people with generalised social anxiety disorder (SAD) were given 600mg of CBD oil prior to a public speaking test, as opposed to a placebo, they experienced significantly less anxiety, difficulty and discomfort during their speech.
But if you want more details then click here to read some of the writings of Dr. Tod Mikuriya, former national administrator of the US government’s marijuana research programs, was quite outspoken on the subject of addiction. The late Dr. Mikuriya stated that no other single drug or substance has as many therapeutic benefits as cannabis, and he never discovered any evidence of cannabis addiction.
Naturally, the testimonies of these experts were based on a comprehensive literature review, an endeavor which we have also undertaken, albeit in a less official capacity. While many new products have been hailed as a panacea in their times, and many web sources certainly allude to this status for CBD, our objective was more modest – presenting ten possible benefits of cannabidiol where sufficient evidence exists to back up the claims.
^ Hayakawa K, Mishima K, Nozako M, Ogata A, Hazekawa M, Liu AX, Fujioka M, Abe K, Hasebe N, Egashira N, Iwasaki K, Fujiwara M (March 2007). "Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance". Neuropharmacology. 52 (4): 1079–87. doi:10.1016/j.neuropharm.2006.11.005. PMID 17320118.
Disclaimer: We always recommend that you speak with a licensed medical practitioner before modifying, stopping, or starting use of any medications. The statements made on this page have not been evaluated by the U.S. Food and Drug Administration (FDA). They are not intended to diagnose, cure or prevent any disease. If a condition persists, please contact your physician or healthcare provider. The information provided is not a substitute for a face-to-face consultation with a healthcare provider, and should not be construed as medical advice.
CBD (Cannabidiol) is a potent, non-psychoactive cannabinoid found in hemp oil. It is typically extracted from industrial hemp plants that are naturally high in CBD and other phytochemicals. It is the most prevalent of over 80 different cannabinoids found in natural hemp. It is commonly used for its therapeutic properties. Cannabidiol is responsible for a wide-range of positive health benefits through its interaction with the body's own endocannabinoid system.
Numerous studies have found results that confirm the ability of marijuana to help anxiety and stress. In 2013 an Israeli study demonstrated that treatment with cannabinoids helped to control emotional responses and prevent stress-related responses for those that had experienced a traumatic experience. In 2015 a group of researchers found that cannabis treatments were effective in reducing anxiety in those suffering from PTSD.
The CBD oil industry is still groundbreaking, but that hasn’t stopped the creative innovators of marketing to pave the road as now there are several CBD oil concentrations to choose from. This is why many buyers are confused by each brand claiming to have the best and the strongest oil on the market. With that said, in order to offer the strongest CBD oil on the market, we had to spike it with our own 99.5%+ pure CBD isolate so that we can reach an amazing 3,000mg CBD oil 1 oz tincture.
Our extracts contain a unique blend of cannabinoids plus terpenes and flavonoids. Cannabinoids are phyto-compounds that are produced by the hemp plant. One of the most commonly known cannabinoids in hemp is non-psychoactive cannabidiol (CBD). Cannabinoids work with the mammalian Endocannabinoid System (ECS), which is a vast receptor system to support homeostasis and health.*
In the United States, non-FDA approved CBD products are classified as Schedule I drugs under the Controlled Substances Act. This means that production, distribution, and possession of non-FDA approved CBD products is illegal under federal law. In addition, in 2016 the Drug Enforcement Administration added "marijuana extracts" to the list of Schedule I drugs, which it defined as "an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant." Previously, CBD had simply been considered "marijuana", which is a Schedule I drug.